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ERS syllabus for postgraduate 
training in respiratory infections: 
a guide for comprehensive 
training
Introduction
Respiratory infections, including tuberculosis, 
represent one of the leading causes of morbidity 
and mortality across the world. They represent 
the deadliest communicable diseases causing 
3.0 million deaths worldwide in 2016 [1]. The 
burden of respiratory infections can be unbearable 
for some health systems: they represent one of the 
most common reasons for doctor visits, regardless 
of age and sex [2].
Although respiratory infections have been 
identified as a mandatory topic in the education and 
training of respiratory physicians, the specialty has 
been faced with several challenges to implement 
training. There are ongoing discussions surrounding 
what is included and excluded epidemiologically 
within the parameters of respiratory infections. Thus 
it is no surprise that, at present, the vast majority of 
European countries do not yet have a formal system 
for educating respiratory physicians, at a specialty 
level, on the knowledge and skills considered 
essential in the diagnosis, treatment and prevention 
of respiratory infections. Furthermore, European 
countries have very different resources dedicated 
to the continuing development of respiratory 
professionals.
Keeping these educational and training 
challenges in mind, the European Respiratory 
Society (ERS) decided to support a group of 
experts in respiratory infections to define the 
core knowledge and skills considered essential to 
manage respiratory infections. The ERS respiratory 
infections educational task force was founded in 
2014 and included 13 experts from six European 
countries (Italy, Germany, UK, the Netherlands, 
Spain and Greece). The task force had two main 
aims: 1) to develop a syllabus to guide the national 
training and education of respiratory physicians in 
the field of respiratory infections, and 2) to help 
structure ERS educational activities on respiratory 
infections.
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Table 1 ERS syllabus for postgraduate training in respiratory infections
Module 1. Pathogens (respiratory microbiology)  
 1 Respiratory microbiology Mandatory
  1.1 Normal bacterial flora  
  1.2 Classification of respiratory microorganisms  
 2 Respiratory bacteria Mandatory
  2.1 Gram positive  
  2.2 Gram negative  
  2.3 Atypicals  
 3 Respiratory viruses Mandatory
  3.1 RNA viruses (seasonal and/or pandemic, emerging)  
  3.2 DNA viruses (seasonal and/or pandemic, emerging)  
 4 Respiratory fungi Mandatory
  4.1 Candida spp.  
  4.2 Aspergillus spp.  
  4.3 Pneumocystis  
  4.4  Other fungi (including Mucor spp., Cryptococcus neoformans, Histoplasma capsulatum, Coccidioides immitis, 
Blastomyces dermatitidis, Paracoccidioides brasiliensis, Exophiala and Scedosporium)
Optional
 5 Mycobacteria Mandatory
  5.1 Mycobacterium tuberculosis  
  5.2 Non-tuberculous mycobacteria (NTM)  
 6 Antimicrobial resistance Mandatory
  6.1 Mechanisms of antibiotic resistance  
  6.2 Multidrug-resistant (MDR) bacteria  
  6.3 Risk factors for MDR bacteria  
  6.4 MDR/extensively drug-resistant (XDR) tuberculosis  
  6.5 Risk factors for MDR/XDR tuberculosis  
  6.6 NTM resistance  
  6.7 Resistance in other microorganisms (anti-fungal and anti-viral resistance) Optional
  6.8 Influenza resistance Optional
 7 Microbiome Optional
Module 2. Host respiratory defence mechanisms against infection  
 1 Natural barriers Mandatory
  1.1 Cilia/primary ciliary dyskinesia  
 2 Innate immune systems Mandatory
  2.1 Complement  
  2.2 Cells  
  2.3 Defensins  
  2.4 Cytokines  
  2.5 Inflammation process  
 3 Adaptive immune systems Mandatory
  3.1 Humoral immunity  
  3.2 Cellular immunity  
 4 Immune reconstitution inflammatory syndrome (IRIS) Optional
Continued
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Table 1 Continued
Module 2. Host respiratory defence mechanisms against infection (cont.)
 5 Pathophysiology of respiratory infections Mandatory
  5.1 Transmission  
  5.2 Infection  
  5.3 Inflammation  
  5.4 Resolution  
Module 3. Epidemiology, burden of disease and risk factors  
 1 Epidemiological burden of respiratory infections Mandatory
  1.2 Bacterial infections  
  1.3 Viral infections  
  1.4 Fungal infections  
  1.5 Mycobacterial infections (tuberculosis and NTM)  
 2 Risk factors for respiratory infections and transmission Mandatory
  2.1 Environmental risk factors  
  2.2 Host risk factors (including other conditions leading to mild immunosuppression, e.g. diabetes mellitus)  
  2.3 Microbial risk factors  
Module 4. Diagnostic techniques for respiratory infections  
 1 Indication and collection of biological specimens Mandatory
  1.1 Noninvasive (blood, urine, bronchoalveolar lavage, throat swabs)  
  1.2 Invasive (sputum, tracheal aspirate, thoracentesis, imaging-guided biopsy, transthoracic fine-needle biopsy)  
 2 Microscopy Optional
 3 Culture Optional
 4 Susceptibility testing Optional
 5 Immunological tests Optional
  5.1 Interferon-γ release assay (IGRA)  
  5.2 Tuberculin skin test  
  5.3 Serology  
 6 Molecular testing Optional
 7 Rapid point-of-care diagnostic tests for viral and bacterial respiratory tract infections Optional
 8  Imaging techniques in relation to infections (including chest radiography, computed tomography, lung 
ultrasounds and magnetic resonance imaging)
Mandatory
Module 5. General principles of antimicrobial therapy  
 1 Antibacterial agents Mandatory
  1.1 Classification and activity (including pharmacokinetics/pharmacodynamics (PK/PD) principles)  
 2 Antiviral agents Mandatory
  2.1 Classification and activity (including PK/PD principles)  
 3 Antifungal agents Mandatory
  3.1 Classification and activity (including PK/PD principles)  
 4 Antimycobacterial agents Mandatory
  4.1 Classification and activity (including PK/PD principles)  
 5 Drug delivery or administration Mandatory
  5.1 Oral  
  5.2 Inhaled  
  5.3 Intravenous  
  5.4 Intramuscular  
Continued
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Table 1 Continued
Module 5. General principles of antimicrobial therapy (cont.)
 6 Drug–drug interaction Mandatory
 7 Antimicrobial adverse events Mandatory
  7.1 Haematological side-effects  
  7.2 Nausea and vomiting  
  7.3 Diarrhoea including Clostridium difficile infection  
  7.4 Ototoxicity  
  7.5 Hepatic toxicity  
  7.6 Nephrotoxicity  
  7.7 Cardiovascular toxicity  
 8  Principles of antimicrobial stewardship (including prevention of infection, infection control, adequate and 
appropriate treatment)
Mandatory
Module 6. Common respiratory tract syndromes  
 1  Common upper respiratory tract syndromes (including acute infective rhinitis, sinusitis, pharyngitis, epiglottitis, 
laryngotracheitis)
Mandatory
 2 Acute bronchitis Mandatory
 3 Bronchiolitis Mandatory
 4 Exacerbation of asthma Mandatory
 5 Exacerbation of chronic obstructive pulmonary disease (COPD) Mandatory
 6 Exacerbation of bronchiectasis Mandatory
 7 Community-acquired pneumonia, including nursing-home pneumonia Mandatory
 8 Nosocomial pneumonia, including ventilator-associated pneumonia Mandatory
 9 Aspiration pneumonia Mandatory
 10 Seasonal influenza Mandatory
 11 Extrapulmonary complications Mandatory
Module 7. Other respiratory infections  
 1 Fungal pulmonary infections Mandatory
 2 Lung abscess Mandatory
 3 Nocardiosis Mandatory
 4 Actinomycosis Mandatory
 5 Parasitic pneumonia Optional
 6 Travel born respiratory infections Mandatory
Module 8. Severe viral respiratory infections  
 1 Viruses Mandatory
  1.1 Severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), H1N1, H5N1  
 2 Pandemics Mandatory
  2.1 Identification  
  2.2 Management  
  2.3 Public health policies  
Module 9. Mycobacterial disease  
 1 Pulmonary tuberculosis Mandatory
 2 Extrapulmonary tuberculosis Mandatory
 3 Latent tuberculosis infection Mandatory
 4 Nontuberculous mycobacterial infections Mandatory
Continued
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Table 1 Continued
Module 10. Chronic respiratory infections in patients with respiratory disease  
 1 Asthma Mandatory
 2 COPD Mandatory
 3 Bronchiectasis Mandatory
 4 Adult cystic fibrosis bronchiectasis Mandatory
Module 11. Pulmonary infections in the immunocompromised host  
 1 Neutropenic patients Mandatory
 2 HIV-infected patients Mandatory
 3 Haematological disorders and malignancy Mandatory
 4 Lung and other solid organ transplant recipients Mandatory
 5 Haematopoietic cell transplant recipients Mandatory
 6 Secondary immunodeficiency induced by drugs and biologicals Mandatory
 7 Primary immune deficiency syndromes Mandatory
Module 12. Pleural infections  
 1 Parapneumonic effusion and empyema Mandatory
 2 Pleuritis Mandatory
  2.1 tuberculosis, bacterial, etc.  
Module 13. Sepsis  
 1 Sepsis, severe sepsis and septic shock Mandatory
  1.1 Virulence factors involved in sepsis  
  1.2 Early recognition and management  
  1.3 Additional therapies  
  1.4 Biomarkers  
  1.5 Clinical management  
Module 14. Prevention of respiratory infections  
 1 Vaccination Mandatory
  1.1 Influenza vaccination  
  1.2 Pneumococcal vaccination  
  1.3 Other vaccinations  
 2 Other prevention measures Optional
  2.1 Smoking cessation  
  2.2 Specific preventive management  
  2.3 Prevention of community-acquired pneumonia  
  2.4 Dental care  
  2.5 Aspiration management  
 3 Infection control Mandatory
  3.1 Infection surveillance  
  3.2 Universal precautions  
  3.3 Isolation and reverse isolation, including specific microbes in cystic fibrosis and bronchiectasis (e.g. Pseudomonas)  
  3.4 Infectious risks to healthcare workers  
  3.5 Tuberculosis control and elimination, including Bacillus Calmette–Guérin (BCG) vaccine  
  3.6 Immunomodulants (synthetic and microbial)  
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Target audience
As previously outlined [3], the target audience for 
the syllabus are qualified respiratory physicians with 
a special interest in respiratory infections. Based on 
the situational analysis and the Delphi surveys, the 
target audience also includes infectious diseases 
specialists, intensive care unit specialists, internists, 
trainees, researchers and microbiologists, working 
in public hospitals or holding an academic position.
Methods
The approach, methods, and processes used 
in this project have been adapted from the ERS 
developed educational harmonisation framework, 
which, to date, has been used in the development 
of seven postgraduate curricula (www.ersnet.org/
professional-development/ers-curriculum-design-
a-summary-of-projects) and four specialised skills-
based training programmes [4].
To develop the syllabus, a list of key topics was 
identified by the expert task force. A modified 
Delphi technique was applied to these topics 
to reach consensus. The Delphi technique is a 
group facilitation method that seeks to obtain 
consensus on the opinions of experts through a 
series of structured questionnaires [5]. Research 
and methods outlined by Heiko [6] were used to 
guide the decisions taken at various stages of this 
study, for example survey design, undertaking data 
collection and analysis.
The Delphi process was phased in three 
rounds (figure 1). Members of ERS Assembly 10 
(respiratory infections) and national experts were 
asked to complete an online questionnaire, which 
was then processed by the ERS office. The results 
were presented to the task force for more detailed 
discussion. The decisions derived from these 
consultations were integrated into the next Delphi 
round (Delphi 1). It is to be noted that although the 
same respondents were contacted in each round, 
there was a drop off in the number of responses 
between rounds. Respondents were asked to rate 
in terms of agreement whether sections should 
be included (mandatory or optional) or excluded. 
A Likert scale from 1 (strongly disagree) to 5 
(strongly agree) was chosen to ensure measurement 
reliability over the three different Delphi rounds. 
Agreement was operationalised through a majority 
of responses in the top two points of the scale 
(measured as the sum of frequencies of agree 
and strongly agree responses). In Delphi studies 
consensus is considered a necessary, but not 
sufficient, condition for agreement concerning the 
inclusion of items [6]. The iteration of rounds was 
also required to establish the stability dimension for 
agreement. Stability was defined as “the consistency 
of responses between successive rounds of a study” 
[7]. Both consensus and stability dimensions were 
investigated in the study.
Final syllabus
The content of the syllabus was organised in 14 
modules, which were considered important and 
necessary topics or aspects forming the basis of 
the respiratory infections domain (table 1).
Conclusion and next steps
The syllabus was developed to clearly define 
the remit for programme designers in the 
implementation of training and education for 
respiratory physicians. ERS is committed to the 
continuing professional development of respiratory 
professionals and will be using the ERS respiratory 
infections syllabus as a basis for several activities 
in the future, including:
●● External courses, such as the respiratory 
infections course (e.g. the course held in Lisbon, 
Portugal, June 2018), postgraduate courses at 
the ERS International Congress, e-learning and 
other educational activities;
●● Respipedia and other online resources;
●● An ERS professional development programme, 
focusing on the eight main disease areas.
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